These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8101637)

  • 1. Reserpinization severs the cooperative but not the oppositional interaction between D1 and D2 receptors.
    Needham PL; Skill MJ; Cowan A; Redfern RJ; Heal DJ
    Neuropharmacology; 1993 Jun; 32(6):515-7. PubMed ID: 8101637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H; Gerlach J; Peacock L
    Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G; LeDuc PA; Whishaw IQ
    Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-activation of D1- and D2-like receptors is unnecessary for stimulated motor behavior in rats depleted of dopamine during development.
    Byrnes EM; Abrams D; Bruno JP
    Behav Brain Res; 1994 Apr; 61(2):205-14. PubMed ID: 7913605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY; Zhou LW; Friedman E; Weiss B
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism.
    Cole DG; Di Figlia M
    Neuroscience; 1994 May; 60(1):115-23. PubMed ID: 7914358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C; Chase TN
    Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 and D2 receptors and circling behavior in rats with unilateral lesion of the entopeduncular nucleus.
    Pazo JH; Murer GM; Segal E
    Brain Res Bull; 1993; 30(5-6):635-9. PubMed ID: 8096164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.